---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-109821"
form_type: "8-K"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2026-09-23T12:01:31+00:00"
generated_at: "2026-09-23T12:05:22.661203+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Adagio Medical launches strategic alternatives review; cuts 25 of 43 employees

## Summary
- Reducing workforce by 25 of 43 FTEs effective Sept 23, 2026; est. $1.3M in cash costs for severance and benefits.
- Cash, equivalents and marketable securities ~$7.7M as of June 30, 2026 (preliminary unaudited).
- Board initiates formal strategic review; may consider acquisition, merger, business combination; no timetable set.
- Will lower 13% senior secured convertible notes conversion price to 85% of VWAP (5-day) during Sept 23–Oct 31, 2026.
- Continuing to advance PMA application for vCLAS ventricular ablation system.

## SEC filing metadata
- accession: 0001104659-26-109821
- form_type: 8-K
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2026-09-23T12:01:31+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.05, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000110465926109821/0001104659-26-109821-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000110465926109821/adgm-20260923x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-109821
- JSON: https://secwatch.observer/filing/0001104659-26-109821.json
- Plain text: https://secwatch.observer/filing/0001104659-26-109821.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.